You searched for "intervention"

2934 results found

Global CI Collaborative: Futures Forum - Webinar Series July 2020

In July 2020, the Global CI Collaborative launched a series of webinars to highlight the challenges and learnings COVID has brought to the cochlear implant world. COVID has changed healthcare practice globally, requiring rapid service reconfiguration and novel pathways to deliver cochlear implantation for all ages...

Octreotide in the medical management of chyle fistula post neck dissection

Chyle leak, although rare (1% and 2.5%), is a well-documented complication following surgical dissection of the neck. Although the left side of the neck is the most common site, chyle fistulas have been reported in the right side of the...

Vocal fold motion impairment following intubation – how likely is it to recover?

Ed’s Choice reviews a timely paper investigating prolonged intubation on vocal fold motion. The current scientific literature is dominated by studies examining COVID-19 and its widespread effects on health and healthcare delivery but will be old news by the time...

Moving towards implanting children below 12 months of age

Newborn hearing screening has ensured that deaf infants are identified soon after birth so that habilitation can begin as early as possible. Cochlear implantation is a key component of early intervention for some children, but it is often not performed...

Complications associated with intra-tympanic steroid injections for sudden sensorineural hearing loss

Around 15,000 people in the UK experience a sudden sensorineural hearing loss (SSNHL) each year, and in the majority of cases the cause is unknown. Treatment options for idiopathic SSNHL include various modalities of steroid treatments which have known limitations...

Lost and sound: exploring hyperbaric oxygen therapy for refractory SSNHL

Can hyperbaric oxygen therapy (HBOT) offer a breakthrough for patients with refractory sudden sensorineural hearing loss (SSNHL)? SSNHL is defined as acute hearing loss of ≥30 decibels in three consecutive frequencies within three days. Typically, it’s treated with two weeks...

Bell’s palsy – antivirals and steroids for all?

The role of antiviral medications in the treatment of Bell’s palsy remains somewhat controversial. Antivirals alone do not appear to be helpful, whereas numerous studies have shown that corticosteroids improve the chance of a full recovery compared to placebo. What...

Temperature-controlled radiofrequency treatment of the nasal valve confers sustained benefit

Aiming to investigate long-term efficacy and safety (three years post treatment), this was an extension of a previous multicentre, prospective, single-blinded, randomised controlled trial that investigated the effectiveness and safety of temperature-controlled radiofrequency treatment (TCRF) to the nasal valve (NV)...

BIOHIT HealthCare to host symposium on gastric cancer at BSG LIVE'24

BIOHIT HealthCare is attending BSG LIVE'24 at ICC Birmingham from the 17th to the 20th of June, where it will be showcasing its broad range of gastrointestinal diagnostic solutions.

Systemic agents in thyroid cancer

For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...

EVOTION: Big data supporting public health policies for hearing loss

Big Data? Biosensors, smart hearing aids and smartphones? The EVOTION Project has it all and more! What will this project tell us about the future of hearing management? Doris-Eva Bamiou, Giorgos Dritsakis and Louisa Murdin, members of the EVOTION team,...

Current management of unilateral sporadic vestibular schwannoma

Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.